Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01035008
Other study ID # 09-006345
Secondary ID
Status Completed
Phase N/A
First received December 4, 2009
Last updated October 19, 2012
Start date December 2009
Est. completion date November 2011

Study information

Verified date October 2012
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

Confocal laser endomicroscopy (CLE) is a novel and highly promising imaging method for that allows in vivo imaging of the mucosal layer at resolution of approximately 1 micron. Cellular and sub-cellular structures as well as capillaries and single red blood cells can be visualized. CLE is now well established as a highly accurate method for distinguishing neoplasia in the gastrointestinal tract lumen via endoscopy. A major new breakthrough is the development of sub-millimeter CLE probes that can be passed via an image guided needle (nCLE) into solid organs and cysts.

It is hypothesized that nCLE will help distinguish the benign, premalignant and malignant cystic lesions of pancreas by visualizing the cellular lining of the cysts, thereby, avoiding unnecessary surgery in patient with benign cysts and guiding to early and effective surgical removal of high risk neoplastic lesions.

A prototype minimal risk nCLE system has been developed that can be passed via standard endoscopic ultrasound needles into the pancreas but FDA clearance for in vivo use is not expected until late 2010. The investigators propose to evaluate this prototype nCLE system in vivo during endoscopic ultrasound (EUS), as an initial pilot study.


Description:

Hypothesis: the confocal laser endomicroscopy imaging of the nCLE can differentiate between non-mucinous, mucinous non- malignant and malignant pancreatic cysts in vivo and has increased sensitivity compared to endoscopic ultrasound-fine needle aspiration (EUS-FNA) tissue sampling. In this pilot study the investigators will primarily evaluate technical feasibility and interobserver agreement.

1. In patients undergoing EUS for suspected pancreatic cysts, the investigators will evaluate the key nCLE image features of non mucinous, mucinous, and malignant pancreatic cystic neoplasms (PCN).

2. The investigators will estimate the initial image quality, feasibility, and interobserver agreement of nCLE

3. The investigators will establish the preliminary accuracy of nCLE to be used for planning a larger comparative trial


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date November 2011
Est. primary completion date November 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients undergoing endoscopic ultrasound for evaluation of pancreatic cysts (including pseudocysts and suspected pancreatic cystic neoplasms) in the gastrointestinal (GI) lab at Mayo Clinic Jacksonville.

Exclusion Criteria:

- Unwilling/unable to consent;

- Solid pancreatic mass on computerized axial tomography/magnetic resonance (CT/MR);

- Allergy to Fluorescein;

- Pregnancy.

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Procedure:
Endoscopic Ultrasound (EUS)
The investigators will do the standard EUS procedure. If a cyst is seen in the pancreas during EUS, the investigators will administer a special dye called fluorescein through the IV, and then use the new fiber-shaped microscope to take pictures of the lining of the cysts.

Locations

Country Name City State
United States Mayo Clinic Jacksonville Florida

Sponsors (2)

Lead Sponsor Collaborator
Mayo Clinic Mauna Kea Technologies

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Differentiate between non-mucinous, mucinous non-malignant & malignant pancreatic cysts in vivo One day (completion of the EUS) No
See also
  Status Clinical Trial Phase
Completed NCT01624363 - Prevalence of Pancreatic Cysts During Routine Endoscopic Ultra Sound N/A
Completed NCT01447238 - Diagnosis of Pancreatic Cysts: Endoscopic Ultrasound With Fine Needle Aspiration (EUS/FNA), Direct Visualization, and Confocal Laser-induced Endomicroscopy-A Pilot Study
Completed NCT01202136 - The Clinical,Radiologic,Pathologic and Molecular Marker Characteristics of Pancreatic Cysts Study
Completed NCT01698710 - Endoscopic Abraxane Injection Into Pancreatic Cysts N/A
Recruiting NCT02110498 - Early Detection of Pancreatic Cystic Neoplasms
Completed NCT00828048 - International Registry for Intraductal Papillary Mucinous Neoplasma
Terminated NCT02494388 - Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions N/A
Terminated NCT01769534 - Registry and Fluid Banking of Pancreatic Cystic Lesions N/A
Recruiting NCT04400357 - Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors N/A
Completed NCT01236300 - In Vivo nCLE Study in the Pancreas With Endosonography of Cystic Tumors N/A
Completed NCT01929460 - A Pilot Study on the Use of Prophylactic Antibiotics for EUS-guided Pancreatic Cyst Aspiration N/A
Completed NCT01883336 - Long Term Follow up of Small Non-inflammatory Pancreatic Cysts
Completed NCT01392027 - Biospecimens for Identification of Diseases of the Pancreas. N/A